Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
pembrolizumab (keytruda) (1 trial)
sqz-eapc-hpv (1 trial)
atezolizumab (Tecentriq) (1 trial)
ipilimumab (yervoy) (1 trial)
nivolumab (opdivo) (1 trial)
sqz-aac-hpv (1 trial)
sqz-pbmc-hpv (1 trial)
Neoplasms (Phase 1)
Trials (3 total)
Trial APIs (7 total)